Isotretinoin

規格

4759-48-2CAS番号

225-296-0EC番号

(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acidIUPAC名

C20H28O2化学式

300.4 g/mol分子量

Isotretinoin; 13-cis-Retinoic acid; 4759-48-2; Accutane; 13-cis-Vitamin A acid; Neovitamin A acid; Claravis; Roaccutane; 13-cis retinoic acid; Amnesteem; Isotrex; Sotret; Isotretinoine; Roaccutan; Teriosal; isotretinoino; Isotretinoinum; Absorica; 13-RA; Roacutan; RETINOIC ACID, 13-cis-; Ro-4-3780; isotretinoina; Myorisan; Zenatane; Ro 4-3780; cis-RA; DTXSID4023177; Ro-43780; (7E,9E,11E,13Z)-retinoic acid; Vitamin a acid, 13-cis; EH28UP18IF; NSC-758156; (2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid; ABSORICA LD; PAT-001; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic acid; CHEBI:6067; DTXCID403177; 13 cis retinoic acid; accure; (2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid; Ro 43780; Ro 4 3780; Cistane; Isotrexin; Oratane; Epuris; Retinoicacid-13-cis; RefChem:5926; Retinoic acid 13-cis-; 13-cRA; Isotretinoin Zinc Salt, 13 cis; D10AD04; D10BA01; NSC329481; 225-296-0; 13-cis-Retinoate; ISOTRETINON; Isotretinoine [INN-French]; Isotretinoinum [INN-Latin]; Isotretinoino [INN-Spanish]; CIP-Isotretinoin; Accutane (TN); MFCD00079542; (2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid; (13cis)-retinoic acid; CHEMBL547; 13-cis-retinoic acid,Isotretinoin; Isotane; (2Z,4E6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid; cis-Retinoic acid; Isosuprea Lidose; Isotretinoin (USP); Sotret (TN); CCRIS 4286; HSDB 3929; 13 Cis-Retinoic Acid; SR-01000076103; EINECS 225-296-0; UNII-EH28UP18IF; BRN 1885770; cis-Retinoate; BML2-E07; Isotretinoin [USAN:BAN:INN]; Isotretinoin CRS; cis retinoic acid; Absorica (TN); Prestwick_642; CAS-4759-48-2; Isotretinoin [USAN:USP:INN:BAN]; (13-cis)-Retinoate; CPD000471891; Isotretinoin (Standard); Tretinoin(Retinoic acid?; 13cRA; Prestwick2_000256; Prestwick3_000256; Spectrum5_001795; Spectrum5_001937; Isotretinoin (JAN/USP); ISOTRETINOIN [MI]; (13-cis)-Retinoic acid; ISOTRETINOIN [INN]; ISOTRETINOIN [HSDB]; ISOTRETINOIN [USAN]; R 3255; Retinoic acid 13-cis-form; Retinoic acid, (13cis)-; ISOTRETINOIN [VANDF]; Lopac0_001081; SCHEMBL38299; BSPBio_000072; BSPBio_001331; BSPBio_003345; ISOTRETINOIN [MART.]; 4-09-00-02388 (Beilstein Handbook Reference); MLS001074662; ISOTRETINOIN [USP-RS]; ISOTRETINOIN [WHO-DD]; SPECTRUM1502013; BPBio1_000080; GTPL7600; orb1308025; orb3139748; GLXC-06189; HMS1361C13; HMS1568D14; HMS1791C13; HMS1921D08; HMS1989C13; HMS2092N07; HMS2095D14; HMS2233A07; HMS3259J09; HMS3263I04; HMS3402C13; HMS3712D14; HMS3884A13; HMS5079D17; ISOTRETINOIN [ORANGE BOOK]; Pharmakon1600-01502013; ISOTRETINOIN [EP MONOGRAPH]; MSK10560; ISOTRETINOIN [USP MONOGRAPH]; Tox21_200093; Tox21_501081; BDBM50031459; EBC-17199; HY-15127R; LMPR01090021; NSC758156; AKOS015841158; Isotretinoin; Tretinoin EP Impurity A; CCG-205158; CS-1864; DB00982; DS-3367; FR27714; LP01081; NC00635; NSC 758156; SDCCGSBI-0051051.P004; IDI1_033801; NCGC00094358-01; NCGC00094358-02; NCGC00094358-03; NCGC00094358-04; NCGC00094358-05; NCGC00094358-06; NCGC00094358-07; NCGC00094358-08; NCGC00094358-09; NCGC00094358-10; NCGC00094358-11; NCGC00094358-12; NCGC00094358-13; NCGC00094358-14; NCGC00094358-15; NCGC00094358-26; NCGC00094358-29; NCGC00257647-01; NCGC00261766-01; RETINOIC ACID 13-CIS-FORM [MI]; BR164589; HY-15127; SMR000471891; SY075786; 13-cis-Retinoic acid, >=98% (HPLC); SBI-0051051.P003; TRETINOIN IMPURITY A [EP IMPURITY]; EU-0101081; NS00010329; R0088; R1779; C07058; D00348; M02448; EN300-1709656; Q287029; SR-01000076103-2; SR-01000076103-5; SR-01000076103-6; SR-01000076103-9; BRD-K76723084-001-05-9; BRD-K76723084-001-22-4; BRD-K76723084-001-23-2; BRD-K76723084-001-24-0; SR-01000076103-10; Z2311575452; Isotretinoin, European Pharmacopoeia (EP) Reference Standard; Isotretinoin, United States Pharmacopeia (USP) Reference Standard; Isotretinoin, Pharmaceutical Secondary Standard; Certified Reference Material; (2Z,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic Acid; (2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoicacid; 3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-2Z,4E,6E,8E-NONATETRANENOIC ACID別名